IP Library Granted Patent US 10,864,216
Granted Patent B2
US 10,864,216 · App. 15/912,166 · Granted Dec 15, 2020

Phenothiazine diaminium salts and their use

Inventors: Colin Marshall (Aberdeenshire, GB); Scott Clunas (Aberdeenshire, GB); John Mervyn David Storey (Aberdeenshire, GB); James Peter Sinclair (Aberdeenshire, GB); Thomas Craven Baddeley (Aberdeenshire, GB); Ahtsham Ishaq (Aberdeenshire, GB); Michael Simpson (Aberdeenshire, GB); Craig Williamson (Guildford, GB); Barry Alan Wood (Aberdeenshire, GB); Claude Michel Wischik (Aberdeenshire, GB); Charles Robert Harrington (Aberdeenshire, GB); Janet Elizabeth Rickard (Aberdeenshire, GB); David Horsley (Aberdeenshire, GB); Yin Sze Loh (Singapore, SG); Karrar Ahmad Khan (West Bridgeford, GB); Christopher Paul Larch (Aberdeenshire, GB)
Assignee: WisTa Laboratories, Ltd.
A61K31/5415A61K9/0053A61K9/2095A61L2/0052A61P31/04A61P31/12A61P31/14A61P31/18A61P33/02A61P33/06A61P35/00C07D279/20A61K9/2893C07C303/32C07C309/04C07C309/05C07C309/30C07C309/35Y02A50/393Y02A50/411
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,864,216
App. No.
15/912,166
Granted
Dec 15, 2020
Kind
B2
Abstract

Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.

Claims (13)

1. A method of treating a disease selected from the group consisting of: skin cancer or melanoma; a viral disease; a bacterial disease; and a protozoal disease, the method comprising administering to a subject in need thereof the compound of the following formula:

or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

2. The method of claim 1 , wherein the administering is oral.

3. The method of claim 2 , wherein the administering is selected from:

(a) about 100 mg of compound, 3 times daily;

(b) about 150 mg of compound, 2 times daily; and

(c) about 200 mg of compound, 2 times daily.

4. The method of claim 1 , wherein the disease is skin cancer or melanoma.

5. The method of claim 1 , wherein the disease is a viral disease.

6. The method of claim 5 , wherein the viral disease is selected from the list consisting of: Hepatitis C; HIV; and West Nile Virus.

7. The method of claim 1 , wherein the disease is a bacterial disease.

8. The method of claim 1 , wherein the disease is a protozoal disease.

9. The method of claim 7 , wherein the protozoal disease is malaria.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2020
From: LARCH, CHRISTOPHER PAUL
To: WISTA LABORATORIES LTD.
Reel/Frame 054090/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2020
From: KHAN, KARRAR AHMAD
To: WISTA LABORATORIES LTD.
Reel/Frame 054090/0593 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2020
From: LOH, YIN SZE
To: WISTA LABORATORIES LTD.
Reel/Frame 054090/0599 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2020
From: MARSHALL, COLIN; CLUNAS, SCOTT; STOREY, JOHN MERVYN DAVID; SINCLAIR, JAMES PETER; BADDELEY, THOMAS CRAVEN; ISHAQ, AHTSHAM; SIMPSON, MICHAEL; WILLIAMSON, CRAIG; WOOD, BARRY ALAN; WISCHIK, CLAUDE MICHEL; HARRINGTON, CHARLES ROBERT; RICKARD, JANET ELIZABETH; HORSLEY, DAVID
To: WISTA LABORATORIES LTD.
Reel/Frame 054090/0667 →
Priority Claims (1)
SG 201101060-0 · Feb 11, 2011 · national
Continuity (4)
Division 15056610 · Feb 29, 2016
Division 13984841
Provisional Application 61485880 · May 13, 2011
Related Publication 20190046537A1 · Feb 14, 2019
Cited By (2)
US 12,263,175 US 12,324,810